Founder
Metanoia Bio Inc.
The startup has developed a biotechnology platform that modifies an evolutionarily conserved pathway to facilitate functional tissue regeneration, targeting conditions such as diabetes, pancreatic cancer, and Alzheimer's Disease. This technology enables healthcare providers to implement effective regenerative therapies, improving patient outcomes in critical health areas.
- Biotechnology
- Healthcare Technology
Updated 7 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a biotechnology platform that modifies an evolutionarily conserved pathway to facilitate functional tissue regeneration, targeting conditions such as diabetes, pancreatic cancer, and Alzheimer's Disease. This technology enables healthcare providers to implement effective regenerative therapies, improving patient outcomes in critical health areas.